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Background:  The urokinase receptor (uPAR) is a key regulator of pericellular proteolysis, cell adhesion and migration expressed mainly on cells 
with infiltrating properties such as monocytes, smooth muscle cells and cancer cells. We hypothesized that increased monocytic uPAR expression in 
circulation is associated with the formation and development of atherosclerosis. 
Methods: A total of 39 male apoE-/- mice were ramdonly divided into high-fat (HF) diet (n=21) and normal diet (n=18). Body weight, blood, 
visceral fat and aortic arteries were collected at an interval of 3 weeks from week 10 to week 16. The percentage of uPAR expressing monocytes 
(PUEM) and the expression of uPAR within different types of atherosclerotic plaques were meassured at each timepoint. In vitro, uPAR expression on 
human peripheral monocytes upon ox-LDL stimulation was detected. Migration activity of monocyte and its CD14+uPAR+ subset was examined. 
Results: PUEM in circulation was significantly higher in animals with HF diet compared with those having normal diet (p<0.03). The numbers of 
uPAR positve macrophages in plaques were increased with the severity of atherosclerosis, showing a following rank order: calcified plaques (CP) > 
fibrous plaques (FP) > early lesions > macroscopically normal areas(p<0.05); the core of CP and FP > the cap of CP and FP. The augmented levels 
of PUEM are associated with feeding time, body weight, visceral fat weight (all p<0.001), and the numbers of positive uPAR macrophages within 
atherosclerotic lesions (r=0.871, p<0.001). In vitro, peripheral monocytes upon ox-LDL stimulation exhibited an increased uPAR expression which 
was inhibited by atorvastatin pretreatment. uPAR antibody markedly suppressed monocyte migration induced by MCP-1. In CD14+uPAR+ monocytes, 
uPA enhenced cell migration through its amino terminal fragment.
Conclusions:  Over-expression of uPAR both in circulating monocytes and in atherosclerotic lesions is associated with the development of 
atherosclerotic plaques. uPAR and its interaction with uPA may contribute to enhenced monocyte migration. Thus, uPAR may be a novel target for 
prevention of uncontrolled monocyte recruitment in inflammatory atherogenic process.
